fda semaglutide Approves Oral Semaglutide: First GLP-1 Weight Loss Pill FDA Approves Oral Semaglutide for

The findings showed for the first time that there is a GLP-1-brain-immune axis that controls inflammation across the body independent of weight loss, even in peripheral organs devoid of GLP1 receptors, said Drucker

Thyroid 34 (2), 252260 (2024)

Specific Risks of Bariatric Surgery Surgery (Gastric Sleeve or Bypass) is a major medical event with long-term physiological changes: Nutrient Malabsorption: Surgery permanently alters how you absorb vitamins (B12, Iron, Calcium), requiring a lifelong commitment to medical-grade supplements

The Preclinical Foundation Before human clinical trials began, the case for GLP-1 agonists in addiction was built on a robust body of animal research spanning more than a decade

Cmo acta